The search textbox has an autosuggest feature. When you enter three or more characters,
a list of up to 10 suggestions will popup under the textbox. Use the arrow keys
to move through the suggestions. To select a suggestion, hit the enter key. Using
the escape key closes the listbox and puts you back at the textbox. The radio buttons
allow you to toggle between having all search items start with or contain the text
you entered in the search box.
levodopa
An amino acid precursor of dopamine with antiparkinsonian properties. Levodopa is a prodrug that is converted to dopamine by DOPA decarboxylase and can cross the blood-brain barrier. When in the brain, levodopa is decarboxylated to dopamine and stimulates the dopaminergic receptors, thereby compensating for the depleted supply of endogenous dopamine seen in Parkinson's disease. To assure that adequate concentrations of levodopa reach the central nervous system, it is administered with carbidopa, a decarboxylase inhibitor that does not cross the blood-brain barrier, thereby diminishing the decarboxylation and inactivation of levodopa in peripheral tissues and increasing the delivery of dopamine to the CNS. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
| Synonym: | | L-dopa | |
| |||
| US brand names: | | Bendopa Dopar Eldopar Laradopa Larodopa Levopa | |
| |||
| Foreign brand names: | | Cidandopa Deadopa Dopaflex Dopaidan Dopal Dopalina Doparkine Doparl Dopasol Dopaston Dopastral Doprin Eldopal Eldopatec Eurodopa Ledopa Maipedopa Parda Veldopa | |
| |||
| Chemical structures: | | (--)-2amino-3-)3,4-dihydroxyphenyl)propanoic acid (--)-3-(3,4-dihydroxyphenyl)-L-alanine 3-hydroxy-L-tyrosine beta-(3,4-dihydroxyphenyl)-L-alanine | |
| |||
